FDA Clears Alere Immunoassay Analyzer
The diagnostic system features objective results interpretation and connectivity capabilities, and can be used to evaluate lateral-flow immunoassays in a wide variety of formats.
Read MorePosted by Elaine Sanchez Wilson | Apr 25, 2017 | Immunoassay, Immunoassay Instrumentation, Immunoassay Reagents & test Kits, Rapid Assays |
The diagnostic system features objective results interpretation and connectivity capabilities, and can be used to evaluate lateral-flow immunoassays in a wide variety of formats.
Read MorePosted by Elaine Sanchez Wilson | Apr 4, 2017 | Immunoassay, Immunoassay Instrumentation, Immunoassay Reagents & test Kits, Rapid Assays |
FDA has reclassified antigen-based rapid influenza virus antigen detection systems intended to detect influenza virus directly from clinical specimens from Class I devices into Class II devices subject to special controls.
Read MorePosted by Elaine Sanchez Wilson | Mar 21, 2017 | Molecular Diagnostics |
The clinical chemistry and immunoassay technologies allow for cost-effective volume growth in a footprint half the size of Abbott’s current diagnostics systems.
Read MorePosted by Elaine Sanchez Wilson | Mar 14, 2017 | Biochemicals & Chemical Reagents |
The new kit facilitates the generation of highly stable europium conjugates, often allowing 10- to 100-fold improved limits of detection compared with other common particles.
Read MorePosted by Elaine Sanchez Wilson | Mar 7, 2017 | Cancer, Unknown Origin & Other Cancer Types |
The tests are based on technology that accurately measures CD44, a tumor-initiating and stem cell-associated biomarker, and total protein levels.
Read More